InvestorsHub Logo
Followers 116
Posts 1877
Boards Moderated 0
Alias Born 11/22/2017

Re: Lykiri post# 181953

Thursday, 07/12/2018 6:17:29 PM

Thursday, July 12, 2018 6:17:29 PM

Post# of 700696
Learn how the analysis of OS (overall survival) and PFS (progression-free survival) helps assess the potential benefit of Immuno-Oncology (I-O).


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News